Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04210037
Title Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications

lung small cell carcinoma

Therapies

APG-1252 + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.